| Clinical Significance: | Myasthenia Gravis is a neurological disorder characterized by a decrease in acetylcholine receptors.
Patients exhibit skeletal muscle weakness and fatigability. Approximately 80% of patients with
Myasthenia Gravis, excluding ocular involvement only, have detectable acetylcholine receptor antibody. |
| Methodology: |
See Individual Assays
|
| Reference Range: | See Laboratory Report |
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
| CPT: | 86041(1), 86042(1), 86043(1) |
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
| Specimen Type: | Serum |
| Specimen Stability: |
|
| Specimen Requirements: |
2 mL (0.7 mL minimum) serum in a Red-top tube or Serum Separator Tube (SST) |
| Transport Temperature: | Refrigerated |
| Set-up/Analytic Time: | 2-8 days |
Home